Effective as of September 14, 2023, Michael Dougherty retired as a member of the Board of Directors of Trevena, Inc., and as a member of the Audit Committee of the Board. Mr. Dougherty?s departure was not the result of any disagreement with the Company on any matter relating to the Company?s operations, policies or practices. Mr. Dougherty has over 35 years of experience in the biopharmaceutical industry, and served on the Company?s Board of Directors since 2013 just prior to its initial public offering.